Marksans Pharma updates acquisition of QliniQ B.V.

M&A / JV 16 Jun 2026 · Announced· ✓ Verified

On 16 Jun 2026, Marksans Pharma Limited filed a General Updates notification with the NSE regarding an acquisition of QliniQ B.V., a Netherlands-based entity. The intimate does not specify transaction value, consideration structure, conditions precedent or expected closure. Further details would be available in full exchange intimations or official company announcements.

Why it mattersCross-border pharma M&A involving Indian listed entity requires corroboration of FEMA/RBI approval and CCI clearance thresholds; verify full intimation schedules and company press release for deal certainty.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals